Russell Investments Group, Ltd. Karyopharm Therapeutics Inc. Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$0.68 - $1.31 $60,070 - $115,724	-88,339 Reduced 93.13%	6,519 $5,000
Q3 2023 Nov 13, 2023	SELL	$1.14 - $1.81 $680 - $1,080	-597 Reduced 0.63%	94,858 $127,000
Q2 2023 Aug 10, 2023	BUY	$1.79 - $4.59 $1,924 - $4,934	1,075 Added 1.14%	95,455 $170,000
Q1 2023 May 09, 2023	SELL	$2.84 - $3.92 $147,055 - $202,977	-51,780 Reduced 35.43%	94,380 $367,000
Q4 2022 Feb 08, 2023	BUY	$2.48 - $5.93 $41,527 - $99,297	16,745 Added 12.94%	146,160 $496,000
Q3 2022 Nov 04, 2022	BUY	$4.08 - $5.82 $82,905 - $118,262	20,320 Added 18.63%	129,415 $705,000
Q2 2022 Jul 29, 2022	BUY	$4.15 - $8.37 $200,648 - $404,681	48,349 Added 79.59%	109,095 $491,000
Q1 2022 May 05, 2022	BUY	$5.91 - $14.38 $354,842 - $863,389	60,041 Added 8516.45%	60,746 $447,000
Q4 2021 Jan 21, 2022	SELL	$5.21 - $8.61 $9,404 - $15,541	-1,805 Reduced 71.91%	705 $4,000
Q3 2021 Nov 08, 2021	SELL	$4.45 - $10.63 $223,207 - $533,190	-50,159 Reduced 95.23%	2,510 $14,000
Q2 2021 Aug 04, 2021	BUY	$8.11 - $11.11 $74,968 - $102,700	9,244 Added 21.29%	52,669 $542,000
Q1 2021 May 10, 2021	SELL	$9.85 - $17.69 $123,184 - $221,231	-12,506 Reduced 22.36%	43,425 $456,000
Q4 2020 Feb 08, 2021	SELL	$14.15 - $17.19 $80,287 - $97,536	-5,674 Reduced 9.21%	55,931 $864,000
Q3 2020 Nov 09, 2020	BUY	$14.14 - $19.71 $464,456 - $647,414	32,847 Added 114.22%	61,605 $898,000
Q2 2020 Aug 05, 2020	BUY	$16.6 - $25.25 $201,822 - $306,989	12,158 Added 73.24%	28,758 $543,000
Q4 2019 Jan 29, 2020	BUY	$9.23 - $19.67 $153,218 - $326,522	16,600 New	16,600 $318,000
Q3 2018 Oct 26, 2018	SELL	$17.03 - $21.18 $74,932 - $93,192	-4,400 Closed	0 $0
Q2 2018 Aug 08, 2018	SELL	$12.0 - $19.88 $4,800 - $7,952	-400 Reduced 8.33%	4,400 $75,000
Q4 2017 Feb 06, 2018	BUY	$9.15 - $11.99 $43,920 - $57,552	4,800	4,800 $47,000

Others Institutions Holding KPTI

# of Institutions

Shares Held

57.6M

Call Options Held

258K

Put Options Held

81.2K

Vanguard Group Inc Valley Forge, PA

7.65M
Shares

$5.05 Million
0.0% of portfolio
Eversept Partners, LP New York, NY

5.55M
Shares

$3.66 Million
0.36% of portfolio
Palo Alto Investors LP Palo Alto, CA

5.1M
Shares

$3.37 Million
0.58% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

4.32M
Shares

$2.85 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.17M
Shares

$2.75 Million
0.0% of portfolio

View Full List

About Karyopharm Therapeutics Inc.

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $52.7M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

More about KPTI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account